Patent: 10,238,666
✉ Email this page to a colleague
Summary for Patent: 10,238,666
Title: | Pharmaceutical compositions and methods |
Abstract: | This invention relates the use of cortisol blockers (e.g., glucocorticoid receptor [GR] antagonists) for the treating or preventing viral infections, treating or preventing treatment resistant prostate cancer, treating or preventing neoplasia, and treating or preventing infection related to acute or chronic injury or disease. |
Inventor(s): | Altschul; Randice Lisa (Cliffside Park, NJ), Theise; Neil David (New York, NY), Kesel; Andreas J. (Munich, DE), Rapkin; Myron (Indianapolis, IN), O\'Brien; Rebecca (Shell Knob, MO), Arment; Anthony R. (Fairborn, OH) |
Assignee: | Pop Test Oncology LLC (Cliffside Park, NJ) |
Application Number: | 15/825,982 |
Patent Claims: | see list of patent claims |
Details for Patent 10,238,666
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Emergent Biosolutions Canada Inc. | BAT | botulism antitoxin heptavalent (a, b, c, d, e, f, g) - (equine) | Solution | 125462 | 03/22/2013 | ⤷ Try a Trial | 2035-08-03 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |